Reed Biotech
Reed Biotech Ltd is a privately held UK life science reagents company selling ELISA kits, antibodies, proximity ligation assays, recombinant proteins, and biochemical kits directly to academic, pharmaceutical, and institutional researchers via a global e-commerce and distributor network.
- Company typePrivate
- Founded-
- HeadquartersWuhan, China
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Reed Biotech does
Reed Biotech Ltd is a privately held UK-domiciled life science reagents company specializing in immunological protein detection products for the research community. Its core portfolio spans ELISA kits (Fast Step, Micro Fast, High Sensitive, and species-specific variants for Human, Mouse, Rat, and other models), a Proximity Ligation Assay platform, primary/secondary/labeling antibodies, recombinant proteins (cytokines), biochemical analysis kits (oxidation/antioxidation, ATP, exosome isolation), and immunology-related reagents for Western Blotting, IHC, and IF. The company's differentiating technologies include Polylysine PolyHRP signal amplification for ELISA and proprietary antibody conjugation methods, consolidated under the VeriQuant™ Immunoassay Series positioned as a simplified, lower-volume, higher-sensitivity alternative to traditional ELISA.
The company operates a product-led growth model, selling directly through its e-commerce website (reedbiotech.com) with global shipping, supplemented by a distributor network for regional coverage. Pricing is unit-based for catalog items (e.g., antibodies at $149-$249 depending on volume) and quote-based for ELISA kits and bulk orders. Its customer base is horizontally segmented across academic researchers, pharmaceutical and biotech companies engaged in drug discovery, and university/institutional laboratories, with no named enterprise customers or large anchor accounts disclosed. Supporting marketing is content-driven, including a publications database, signaling pathway resources, FAQ, discussion forum, and online calculation tools, alongside a 14-paper publication track record in 2025-2026 in journals with impact factors ranging from 11.6 to 18.5.
Reed Biotech reports no disclosed revenue, headcount, funding history, ownership structure, or named management team. The legal entity is Reed Biotech Ltd, doing business as Reed Biotech, with sub-brand VeriQuant™. The company is operating, with an active website and 2026 copyright, but its scale, financial profile, and ownership are not evidenced in the source material, making any revenue or valuation estimate necessarily low-confidence.
Reed Biotech firmographics
Firmographics- Name
- Reed Biotech
- Legal name
- Reed Biotech Ltd
- Website
- https://reedbiotech.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Reed Biotech Ltd is a privately held UK life science reagents company selling ELISA kits, antibodies, proximity ligation assays, recombinant proteins, and biochemical kits directly to academic, pharmaceutical, and institutional researchers via a global e-commerce and distributor network.
- Ownership category
- akta.pro rank
Reed Biotech industry classification
Industry- Product category
- Life Science Research Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)
Keywords
Where Reed Biotech is headquartered
LocationHeadquarters
- HQ city
- Wuhan
- HQ country
- China
- HQ region
- Asia
Markets served
Reed Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- ELISA Kits Sales: Sale of various ELISA kit product lines including Fast Step, Micro Fast, High Sensitive, Human, Mouse, Rat, and other species-specific kits for biomarker detection research.
- Antibody Products: Sale of primary antibodies, secondary antibodies, and labeling antibodies for Western Blotting, IHC, IF, and IP applications.
- Biochemical Analysis Reagents: Biochemical reagent kits for oxidation/antioxidation studies, ATP detection, and exosome isolation for various sample types including serum, plasma, and tissue homogenates.
- Recombinant Proteins: Cytokines and other recombinant proteins produced via recombinant DNA technology in bacterial or mammalian expression systems.
- VeriQuant Consumables: Consumables and accessory products supporting the VeriQuant immunoassay platform.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Antibody products priced by volume |
| Other | Pay-as-you-go | ELISA kits available in 96T and 48T formats |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Reed Biotech product offering
Product offeringCore offering
Reed Biotech Ltd manufactures and sells life science research reagents focused on immunological protein detection and quantification. The portfolio includes ELISA kits (Fast Step, Micro Fast, High Sensitive, and species-specific formats), antibody products (primary, secondary, and labeling antibodies), recombinant proteins and cytokines, biochemical analysis kits (oxidation/antioxidation, ATP detection, exosome isolation), and immunology-related reagents for Western Blotting, IHC, and IF. The company's proprietary VeriQuant Immunoassay Series and Polylysine PolyHRP Signal Amplification technology differentiate its ELISA offerings by enabling streamlined protocols, reduced sample volumes, and enhanced sensitivity for low-abundance targets.
Product overview
Reed Biotech Ltd is a life science reagents company specializing in immunological protein products for the research community. The company offers a comprehensive portfolio organized around several core product lines: (1) Proximity Ligation Assay (PLA) for in-situ detection; (2) VeriQuant™ Immunoassay Series - a next-generation ELISA platform featuring simplified protocols and enhanced sensitivity; (3) Complete ELISA Kit portfolio including Fast Step ELISA Kits (with polylysine polyHRP signal amplification), Micro Fast ELISA Kits, and High Sensitive ELISA Kits available for Human, Mouse, Rat, and other species; (4) Antibody products encompassing Primary Antibodies, Secondary Antibodies, and Labeling Antibodies (including HRP conjugates); (5) Biochemical Analysis products including Cell Function Reagents, Biochemical Assay Kits, and Exosome Kits; (6) Recombinant Proteins (Cytokines); and (7) Immunology Reagents for Western Blotting, Immunohistochemistry, and Immunofluorescence. The company emphasizes advanced equipment and facilities to ensure product quality and experimental accuracy.
Differentiator
Problem solved
Functional benefit
Brands
- VeriQuant: Immunoassay series product line including VeriQuant and VeriQuant Consumables Set for protein detection
Products and services
- Proximity Ligation Assay (PLA)
- VeriQuant Immunoassay Series
- VeriQuant Consumables Set
- ELISA Kits (Fast Step, Micro Fast, High Sensitive, and species-specific)
- ELISA Auxiliary Reagent
- Antibodies (Primary, Secondary, and Labeling)
- Biochemical Analysis Products (Cell Function Reagents, Biochemical Assay Kits, Exosome Kit)
- Recombinant Protein (Cytokines)
- Immunology Related Reagents (Western Blotting, Immunohistochemistry, Protein Marker)
Quantifiable outcome
- Micro sample requirement of 1-5 μL enables research with scarce or precious samples
- +2 more outcomes
Companies that use Reed Biotech
Customer profileSegments3 records
Ideal customer profiles3 records
Reed Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Reed Biotech partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights6 records
Reed Biotech competitors and assessment
Company assessmentDirect peers
- Cell Signaling Technology (CST): Specialist antibody and immunoassay vendor for signaling-pathway and Western blot/IHC applications; competes head-on with Reed Biotech's antibody and immunology reagent lines for the same academic researcher buyer.
- Elabscience: Direct-to-customer e-commerce vendor of ELISA kits, antibodies, and recombinant proteins at competitive price points, closely mirroring Reed Biotech's product-led GTM and catalog breadth.
- Bio-Rad Laboratories: Established ELISA kit and life science reagent manufacturer with a broad catalog comparable to Reed Biotech's, targeting academic, clinical, and biotech research labs globally.
- Abcam: Leading antibody supplier with deep coverage of WB, IHC, IF, and ELISA applications; directly comparable to Reed Biotech's antibody portfolio and adjacent immunoassay offering.
- PeproTech (part of Thermo Fisher): Specialist manufacturer of recombinant cytokines and growth factors, directly competing with Reed Biotech's recombinant protein/cytokine product line for the same research-use customer base.
- MyBioSource: Online catalog of ELISA kits, antibodies, and recombinant proteins sold direct-to-researcher at competitive pricing, mirroring Reed Biotech's e-commerce-led approach to the academic life science market.
- RayBiotech: Specialist in ELISA kits and antibody arrays for biomarker discovery; offers a comparable catalog to Reed Biotech's ELISA and PLA-style immunoassay products with similar researcher-segment focus.
- Bio-Techne (R&D Systems / Novus Biologicals / Tocris): Direct competitor across ELISA kits, recombinant proteins/cytokines, and primary antibodies for life science research, overlapping heavily with Reed Biotech's product catalog and target academic/biopharma customer base.
Broad incumbents
- Millipore Sigma (Merck Life Science): Broad-line reagents and immunoassay kits vendor whose catalog overlaps substantially with Reed Biotech's biochemical reagents, antibodies, and ELISA offerings for research customers.
- Thermo Fisher Scientific (Invitrogen / eBioscience / Pierce): Dominant life science tools incumbent whose Invitrogen, eBioscience, and Pierce brands cover ELISA kits, antibodies, and reagents that compete with most of Reed Biotech's catalog, though Thermo Fisher operates at vastly greater scale and breadth.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Reed Biotech social profiles
Digital presenceReed Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Reed Biotech leadership team
Management profileNumber of profiles
Reed Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Reed Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Reed Biotech
What does Reed Biotech do?
Reed Biotech Ltd manufactures and sells life science research reagents focused on immunological protein detection and quantification. The portfolio includes ELISA kits (Fast Step, Micro Fast, High Sensitive, and species-specific formats), antibody products (primary, secondary, and labeling antibodies), recombinant proteins and cytokines, biochemical analysis kits (oxidation/antioxidation, ATP detection, exosome isolation), and immunology-related reagents for Western Blotting, IHC, and IF. The company's proprietary VeriQuant Immunoassay Series and Polylysine PolyHRP Signal Amplification technology differentiate its ELISA offerings by enabling streamlined protocols, reduced sample volumes, and enhanced sensitivity for low-abundance targets.
Is Reed Biotech a public or private company?
Reed Biotech is a private company. It is classified as unknown and is currently operating.
When was Reed Biotech founded?
Reed Biotech was founded in -1. It employs 51 to 100 people.
Where is Reed Biotech based?
Reed Biotech is headquartered in Wuhan, China, in the Asia region.
How does Reed Biotech make money?
Five revenue lines are on record. ELISA Kits Sales are the primary driver. The others are antibody Products, biochemical Analysis Reagents, recombinant Proteins and veriQuant Consumables.
Who are Reed Biotech's main competitors?
Direct peers on record are Cell Signaling Technology (CST), Elabscience, Bio-Rad Laboratories, Abcam, PeproTech (part of Thermo Fisher), MyBioSource, RayBiotech and Bio-Techne (R&D Systems / Novus Biologicals / Tocris). Broad incumbents are Millipore Sigma (Merck Life Science) and Thermo Fisher Scientific (Invitrogen / eBioscience / Pierce).
Does Reed Biotech have an API?
No public API is recorded for Reed Biotech.
What industry is Reed Biotech in?
Reed Biotech's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.